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Although communication between neurons is
considered a function of the synapse, neurons also
release neurotransmitter from their dendrites. We
found that dendritic transmitter release coordinates
activity across distinct neuronal populations to
generate integrative homeostatic responses. We
show that activity-dependent vasopressin release
from hypothalamic neuroendocrine neurons in the
paraventricular nucleus stimulates neighboring
(100 mm soma-to-soma) presympathetic neurons,
resulting in a sympathoexcitatory population re-
sponse. This interpopulation crosstalk was engaged
by an NMDA-mediated increase in dendritic Ca2+,
influenced by vasopressin’s ability to diffuse in the
extracellular space, and involved activation of CAN
channels at the target neurons. Furthermore, we
demonstrate that this interpopulation crosstalk plays
a pivotal role in the generation of a systemic, poly-
modal neurohumoral response to a hyperosmotic
challenge. Because dendritic release is emerging
as a widespread process, our results suggest that a
similar mechanism could mediate interpopulation
crosstalk in other brain systems, particularly those
involved in generating complex behaviors.
INTRODUCTION
Information processing in the CNS involves a wide array of
spatiotemporal scales, ranging from temporally fast and spatially
precise (critical for coherent spike timing between two neurons;
Galarreta and Hestrin, 2001), to temporally slow and spatially
diffuse, a modality best suited for the coordination of activity
within or across entire neuronal populations (Fuxe et al., 2007;
Leng and Ludwig, 2008). Despite the importance of the latter in
the generation of complex behaviors (Ludwig and Leng, 2006),
the precise signaling mechanisms underlying interpopulation
crosstalk in the brain remain largely unknown.1036 Neuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc.Neuropeptides are increasingly recognized as unique signals
involved in information processing in the brain (Leng and Ludwig,
2008; Salio et al., 2006). They are abundantly found in dendrites
(Guan et al., 2005; Pow and Morris, 1989), their release is
generally not confined to or targeted at synaptic/postsynaptic
sites, and given their relatively long half-lives (Mens et al.,
1983), they can diffuse in the extracellular space (ECS) to act
on distant targets. Thus, unlike classical fast-acting neurotrans-
mitters, neuropeptide signaling lacks temporal and spatial preci-
sion, making it ideally suited tomediate communication between
populations of neurons (Fuxe et al., 2007; Landgraf and
Neumann, 2004; Ludwig and Leng, 2006).
Neuropeptides are widely used as signaling molecules in the
hypothalamus, particularly within the supraoptic and paraven-
tricular nuclei (SON and PVN, respectively). These centers are
critically involved in the generation of complex polymodal
homeostatic responses, consisting of orchestrated activities of
autonomic and neuroendocrine networks (Buijs and Van Eden,
2000; Swanson and Sawchenko, 1980). During disturbances of
fluid/electrolyte homeostasis, activation of magnocellular
neurosecretory (MNNs) and presympathetic neurons in the
PVN results in the concerted systemic release of the hormone
vasopressin (VP), along with an increase in renal sympathetic
outflow, respectively, acting together to restore fluid/electrolyte
balance (Bourque, 2008; Toney and Stocker, 2010). Importantly,
an imbalanced interaction among these systems results in
maladaptive responses characteristic of disease conditions,
including stress and hypertension (Ely, 1995; Esler et al., 1995).
Thus, generation of homeostatic responses by the PVN repre-
sents an ideal paradigm to study interpopulation signaling
mechanisms within the brain, both under physiological and
pathological conditions.
In addition to playing key roles in the processing and integra-
tion of synaptic inputs, dendrites are recognized to be major
sources of brain neuropeptides (Guan et al., 2005; Pow and
Morris, 1989), MNNs being one of the best-studied prototypes
of dendritic peptide release (Ludwig and Leng, 2006). Besides
releasing their peptide content from neurohypophyseal axonal
terminals into the circulation, MNNs also release VP and
oxytocin (OT) locally from their dendrites, serving as a powerful
autocrine signal by which they autoregulate their activity (Gou-
ze`nes et al., 1998; Ludwig and Leng, 1997). However, whether
Figure 1. Dendro-Somatic and Dendro-
Dendritic Interrelationships between
Presympathetic and Magnocellular Neuro-
secretory PVN Neurons
(A–F) Confocal images showing the topographical
segregation between immunoreactive magnocel-
lular neurosecretory VP (green) and retrogradely
labeled presympathetic PVN-RVLM (red) neuronal
somata. In (A) and (B), the insets are shown at
progressively higher magnification to better depict
the presence of thick and varicose VP dendrites
within the presympathetic neuronal compartment.
Additional examples of VP dendrites extending
from the lateral magnocellular subnucleus (C) into
the three main presympathetic PVN subnuclei,
including the dorsal cap (D), parvocellular ventro-
medial (E), and parvocellular posterior (F), are
shown.
(G) PVN-RVLM neurons surrounded by VP
dendrites are shown at high magnification.
(H) Low-magnification image of the PVN showing
that the vast majority of immunoreactive VP
(green) and OT (red) axons emerge from the PVN,
running laterally and ventrally toward the median
eminence. The box depicts amagnified view of the
area between lines. 3V, third ventricle.
(I) Image showing thick, immunoreactive VP
processes (green), which are also MAP2 immu-
noreactive (white, arrows), nearby a PVN-RVLM
neuron (red, asterisk). Note the abundance of
MAP2 processes that are negative for VP.
(J) Image showing DBH-immunoreactive boutons
(white, arrows) abutting VP-immunoreactive pro-
cesses (green) near a PVN-RVLM neuron (red,
asterisk).
Vertical and horizontal arrows point dorsally and
ventrally, respectively. Scale bars represent 20 mm
in (A)–(G), 200 mm in (H), and 5 mm in (I) and (J).
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Neurosecretory-Autonomic Interpopulation Crosstalkdendritically released peptides from MNNs can act beyond their
own secreting population, to mediate interpopulation crosstalk,
has not yet being explored. Using the magnocellular neuro-
secretory system as a unique model system, we tested the
hypothesis that dendritic peptide release constitutes a powerful
interpopulation signaling modality in the brain. More specifically,
we assessed whether dendritically released VP mediates
crosstalk between neurosecretory and presympathetic hypotha-
lamic neurons in the context of homeostatic neurohumoral
responses to an osmotic challenge.
Using a combination of in vitro approaches in acute hypotha-
lamic slices, including patch-clamp electrophysiology, confocal
imaging, and laser photolysis of caged molecules, we demon-
strate that dendritically released VP from a single stimulated
neurosecretory neuron evoked a direct excitatory response in
presympathetic neurons located 100 mm away. Moreover, we
found that activity-dependent dendritic VP release from the
whole population of neurosecretory neurons translated into a
diffusible pool of peptide that tonically stimulated presympa-
thetic neuronal activity. Finally, using an in vivo homeostatic
challenge, we show that dendritic VP release is critical for therecruitment of presympathetic neurons, resulting in an optimal
sympathoexcitatory outflow during a homeostatic challenge
that requires an orchestrated neurosecretory and sympathetic
response.
RESULTS
Intimate Dendro-Somatic and Dendro-Dendritic
Interrelationships between Presympathetic and
Magnocellular Neurosecretory PVN Neurons
It is well documented that neurosecretory and presympathetic
neuronal somata in the PVN are anatomically compartmental-
ized within specific subnuclei (Swanson and Kuypers, 1980;
Swanson and Sawchenko, 1980). Using a combination of retro-
grade tract tracing and immunohistochemistry to identify pre-
sympathetic PVN neurons that innervate the rostroventrolateral
medulla (RVLM; PVN-RVLM neurons) and VP MNNs, respec-
tively, we verified this early observation (Figure 1A). However, a
more detailed analysis revealed that thick and varicose dendritic
processes from VP MNNs extended beyond their own neuronal
compartment, coming in close proximity to somatodendriticNeuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc. 1037
Figure 2. Presympathetic PVN Neurons Express Functional V1a
Receptors
(A–D) Sample confocal images at low- (A) and high (B–D)-magnification
showing CTB retrogradely labeled PVN-RVLM neurons (blue) and V1a
receptor immunoreactivity (green; Millipore primary antibody) in the PVN. In (B)
and (C), examples of two PVN-RVLM neurons showing dense V1a-immuno-
reactive clusters, respectively, are depicted. In (D), the squared area in (B) is
shown at an expanded scale to better show V1a-immunoreactive clusters
(arrows) located at the surface of the shown dendrite. Asterisks in (B) and (C)
indicate the soma of the same sampled neuron.
(E) Single-cell V1a mRNA expression in identified PVN-RVLM and EGFP-VP
neurons. A nontemplate negative control is shown in the right lane, and a small
piece of a DNA ladder is shown in the left lane.
(F) A puff of VP (1 mM, arrowheads) delivered directly onto a presympathetic
PVN-RVLM neuron evokes a high-frequency burst of action potentials.
(G) Sample trace showing that in the presence of TTX (0.5 mM), puffs of VP of
decremental durations depolarized a presympathetic PVN neuron in a pro-
portionally decremental manner. Note the presence of Ca2+ spikes (arrow).
(H and I) Summary data of VP effects on firing activity (H) and membrane
potential (I) in presympathetic neurons (n = 16). Error bars represent SEM. **p <
0.01 and ***p < 0.001. antag., antagonist.
Scale bars represent 20 mm in (A) and (B) and 2.5 mm in (D). See also Figure. S1.
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Neurosecretory-Autonomic Interpopulation Crosstalkelements of presympathetic neurons in the ventromedial, dorsal
cap, and posterior parvocellular subnuclei (Swanson and
Kuypers, 1980) (Figures 1B–1G). The identity of these processes
as dendrites was confirmed bymicrotubule-associated protein 2
(MAP2) immunoreactivity (Figure 1I) and by being abutted by
numerous dopamine b hydroxylase (DBH)-immunoreactive
presynaptic boutons (Figure 1J). Conversely, VP axons ran
laterally out of the PVN boundaries, then turned ventrally and
caudally toward the median eminence (Figure 1H) (Swanson
and Kuypers, 1980). These studies support thus a distinctive
anatomical microenvironment that would enable dendro-
dendritic/somatic communication from neurosecretory to pre-
sympathetic neurons, possibly via dendritically released VP.
Activation of V1a Receptors in Presympathetic
PVN Neurons Increases Their Firing Activity via a
Ca2+-Dependent Activation of a CAN Channel
To determine if presympathetic neurons sense dendritically
released VP from MNNs, we first assessed for the expression
of V1a receptors (the most common type of VP receptor found
in the brain; Zingg, 1996) in retrogradely labeled PVN-RVLM neu-
rons. As shown in Figures 2A–2D,we found a dense V1a receptor
immunoreactivity in somatodendritic regions of presympathetic
neurons. Similar results were found with an alternative V1a anti-
body (Figure S1 available online), recently shown to label V1a
receptors in olfactory bulb neurons (Tobin et al., 2010). The
resolution of the light microscopic approach, however, does
not readily distinguish V1a clusters located near the surface
membrane of PVN-RVLM neurons from ones potentially located
at presynaptic terminals. Further supporting the expression of
V1a receptors by PVN-RVLM neurons, however, we report
expression of V1a receptor mRNA in this neuronal population
(Figure 2E).
Focal application of VP onto presympathetic PVN neurons
resulted in direct membrane depolarization and increased
firing discharge (n = 16, p < 0.001; Figures 2F–2I). VP effects
were almost completely blocked by a selective V1a receptor
antagonist (b-mercapto-b,b-cyclopentamethylenepropionyl1,
[O-me-Tyr2, Arg8]-VP, 1 mM; p < 0.01, n = 8; Figure 2H) but
persisted in the presence of the ionotropic glutamate and
GABAA receptor antagonists kynurenate (1 mM) and bicuculline
(20 mM) (basal, 0.30 ± 0.13 Hz; VP, 2.75 ± 0.53 Hz; p < 0.01, n = 6)
or in the presence of a low Ca2+ synaptic block media (basal,
0.58 ± 0.38 Hz; VP, 3.85 ± 0.38 Hz; p < 0.02).
The VP-mediated increase in firing activity in presympathetic
neurons was preceded (3.1 ± 0.8 s) by an increase in [Ca2+]I
(p < 0.01, n = 8; Figures 3A–3C) and was abolished by chelation
of intracellular Ca2+ with BAPTA (10 mM) (n = 8; Figure 3D). In
voltage-clamp mode, VP evoked an outwardly rectifying current
with an apparent reversal potential of 15 mV (Figure 3E).
Taken together, these results support the involvement of a
Ca2+-activated nonselective cation current (CAN) (Petersen,
2002). We found PVN-RVLM neurons to express dense immuno-
reactivity (Figures S2A–S2D) and mRNA (Figure S2E) for TRPM4
channels, amajor CAN channel member of the transient receptor
potential (TRP) family (Ullrich et al., 2005), and previously re-
ported in the hypothalamus (Ghamari-Langroudi and Bourque,
2002; Teruyama and Armstrong, 2007; Teruyama et al., 2011).1038 Neuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc.
Figure 3. VP Effects on Presympathetic Neurons Involve an Increase in [Ca2+]I and Activation of a CAN Channel
(A) Sample traces showing simultaneous D[Ca2+]I (lower) and membrane potential (upper) measurements in a PVN-RVLM neuron in response to bath-applied VP
(1 mM, line). Note that the increase in D[Ca2+]I preceded the increase in firing discharge.
(B) Representative pseudocolor (upper) and black and white (lower) images of VP-evoked Ca2+ changes in the PVN-RVLM neuron shown in (A). Image numbers
correspond to the time points shown in (A).
(C) Summary data showing mean VP-evoked Ca2+ changes (F/F0) in presympathetic PVN neurons (n = 8). **p < 0.01.
(D) Sample trace and summary data showing that chelation of intracellular Ca2+ with BAPTA (10 mM) in the patch pipette prevented VP excitatory effect (puff,
arrowhead) in presympathetic PVN neurons (n = 8).
(E) Sample trace in voltage-clamp mode showing a VP-mediated (puff, arrowhead) inward current (IVP) in a presympathetic PVN neuron. The right panel shows a
mean I/V plot of IVP evoked at various holding potentials (n = 5).
Error bars represent SEM. See also Figure S2.
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Neurosecretory-Autonomic Interpopulation CrosstalkWe also found that VP excitatory effects on PVN-RVLM neurons
were blocked by flufenamic acid (FFA; 200 mM) (n = 9; Fig-
ure S2F), a relatively specific blocker of TRPM4/TRPM5 chan-
nels (Ullrich et al., 2005). In the presence of FFA, PVN-RVLM
neurons were still capable of displaying a burst of action poten-
tials in response to a puff of 20 mMNMDA (n = 3; data not shown),
indicating that FFA effects were not due to nonspecific effects on
overall neuronal function or due to changes in PVN-RVLM
responsiveness to NMDA. Further studies, however, are needed
to precisely identify the molecular identity of the CAN channel
underlying VP actions in presympathetic neurons.
Dendritic Release of VP Mediates Cell-Cell
Communication between Neighboring Neurosecretory
and Presympathetic Neurons
To directly probe for a crosstalk between MNNs and presympa-
thetic neurons, we developed an approach using transgenic
EGFP-VP rats (Ueta et al., 2005) that received an injection of a
fluorescent retrograde tracer in the RVLM (Figure S3). Our
approach consisted of selectively activating individual VP
neurons using laser photolysis of caged NMDA while simulta-
neously monitoring the electrical activity of neighboring presym-
pathetic neurons in acute hypothalamic slices. To validate this
approach, we show that laser photolysis of caged NMDA onto
restricted somatodendritic regions of patched EGFP-VP neuro-
secretory neurons induced reproducible inward currents along
with a concurrent high-frequency burst of action potentials (Fig-ure 4A), previously shown to efficiently evoke dendritic release
of peptides from MNNs in brain slices (Kombian et al., 1997).
Moreover, photolysis of caged NMDA in the somata of Fluo-
5F-loaded EGFP-VP neurons increased [Ca2+]i levels, which
rapidly propagated into dendritic compartments (Figure S4).
To test the hypothesis that dendritic VP release acts as a
crosstalk signal between neurosecretory and presympathetic
neurons, we then obtained patch recordings from PVN-RVLM
neurons and assessed their responses to photolysis of caged
NMDA in neighboring EGFP-VP neurons. On average, three
different EGFP-VP neurons were photoactivated per patched
PVN-RVLM neuron. The mean distance between the somata of
presympathetic and the photoactivated VP neurons was
111.6 ± 7.9 mm. Photolysis of caged NMDA at the somata of
individual EGFP-VP neurons consistently evoked an excitatory
response in neighboring PVN-RVLM neurons, characterized by
a burst of activity, which was underlain by a membrane depolar-
ization (n = 38 EGFP-VP neurons/11 PVN-RVLM neurons, p <
0.001; Figure 4B). Responses in presympathetic neurons
occurred with a mean latency of 3.5 ± 1.0 s following photolysis
in neighboring EGFP-VP neurons. In a few cases (n = 4),
stimulation of an EGFP-VP neuron failed to evoke a response
in PVN-RVLM neurons, which were, however, responsive to
other EGFP-VP neurons in the same preparation.
Direct photolysis of caged NMDA onto the recorded
neurons (EGFP-VP or presympathetic) resulted in an almost
instantaneous effect (p < 0.05, n = 11; Figure 4). Importantly,Neuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc. 1039
Figure 4. Photoactivation of Neurosecretory VP Neurons Evokes a V1a Receptor-Mediated Excitatory Response in Neighboring Presympa-
thetic Neurons
(A) Inward currents evoked in a patched EGFP-VP neuron following photolysis of caged NMDA onto various somatodendritic regions of interest (ROI) (1–3). Note
that photolysis in an ROI a few microns away from the recorded neuron (4) failed to evoke a response. (A2) Repetitive laser photolysis of caged NMDA onto the
same EGFP-VP neuron evoked reproducible inward currents (upper trace), membrane depolarizations (lower trace), and bursts of action potentials (right traces).
(B) Slice containing a patched presympathetic PVN-RVLM neuron (red, asterisk) and neighboring EGFP-VP neurons (green, 1–4) that were activated with
photolysis of caged NMDA. (B2) Direct uncaging of NMDA onto the patched presympathetic neuron (asterisk, yellow flashes) evoked a burst of action potentials.
(B3) Burst of action potentials recorded in the patched presympathetic neuron in response to uncaging of NMDA onto the EGFP-VP neurons shown in (B1) (1–4,
red flashes). Note the delayed response in the PVN-RVLM neurons compared to (B2).
(C) Combined DIC and fluorescence image of a slice containing a patched presympathetic neuron (asterisk) and neighboring EGFP-VP neurons (green). Arrow
points to the stimulated EGFP-VP neuron. The dashed line delimits the ventral border of the lateral magnocellular subnucleus. (C2) Presympathetic neuronal
responses to uncaging of NMDA onto the recorded PVN-RVLM neuron (upper traces) or onto an EGFP-VP neuron (arrow in C1, and lower traces) in control ACSF
(left) and in the presence of a V1a receptor antagonist (right). (C3) Summary data of mean changes in the number of action potentials, action potential frequency,
andmembrane potential in presympathetic PVN-RVLM neurons, evoked by photolysis of caged NMDA onto the presympathetic neurons themselves (n = 11, left)
or onto EGFP-VP neurons in the absence (n = 38, middle) or presence (n = 7, right) of the V1a antagonist. Error bars represent SEM. *p < 0.01 and **p < 0.001
versus respective ACSF.
See also Figures S3, S4, S5, and S6.
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Neurosecretory-Autonomic Interpopulation Crosstalkpresympathetic responses to photoactivation of EGFP-VP
neurons were almost completely blocked following bath applica-
tion of the V1a receptor antagonist Figure 4C). No relationship
between the uncaging distance and magnitude or delay of the
evoked response was observed.1040 Neuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc.Although action potentials are necessary for axonal VP
release, dendritic release can occur in a Ca2+-dependent but
action potential-independent manner (Ludwig et al., 2002).
Thus, to rule out a potential, but unlikely, contribution of VP
released from an axon collateral within the PVN (Hatton et al.,
Figure 5. The NMDA-Mediated Crosstalk between Neurosecretory
VP and Presympathetic PVN-RVLM Neurons Is Not Dependent on
Action Potential Firing
(A) Sample of a slice containing a patched presympathetic PVN-RVLM neuron
that was loaded with Alexa Fluor 555 (red, asterisk) and neighboring EGFP-VP
neurons (green) that were photoactivated with caged NMDA. ‘‘1,’’ ‘‘2,’’ and ‘‘3’’
indicate three EGFP-VP neurons that were simultaneously activated by NMDA
uncaging. (A2) Representative traces obtained from the recorded PVN-RVLM
neuron following five repetitive photolysis of caged NMDA directly onto the
recorded cell (upper trace, yellow flashes) or in response to simultaneous
photolysis onto the three EGFP-VP neurons (1–3, red flashes) shown in (A1), in
control ACSF + 1 mM TTX (middle trace), and following bath application of the
V1a receptor antagonist + TTX (lower trace).
(B) Summary data of mean changes in PVN-RVLM membrane potential
evoked in the presence of TTX following photolysis of caged NMDA onto the
presympathetic neurons themselves (n = 6, blue bar) or onto EGFP-VP neurons
(red bars) in the absence (n = 18, middle bar) or presence (n = 14, right bar) of
the V1a receptor antagonist. Error bars represent SEM. *p < 0.01 versus
respective ACSF.
(C) Another example showing a recorded presympathetic PVN-RVLM neuron
(Alexa Fluor 555; red) and a photoactivated EGFP-VP neuron (green, arrow).
(C2) Sample traces obtained from the PVN-RVLM neuron from (C1) following
photolysis of caged NMDA in the presence of 1 mM TTX directly onto the PVN-
RVLM neuron itself (asterisk, upper trace, yellow flash) or onto an EGFP-VP
neuron (red flashes), in control ACSF (middle trace), and following bath
application of the V1a receptor antagonist (lower trace),in the presence of TTX.
Scale bars represent 15 mm.
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Neurosecretory-Autonomic Interpopulation Crosstalk1985; Ludwig, 1998), experiments were repeated in the presence
of 1 mM tetrodotoxin (TTX). Under these conditions, photolysis of
NMDA onto EGFP-VP neurons still evoked amembrane depolar-
ization in neighboring PVN-RVLM neurons (n = 18), effects that
were blocked by the V1a receptor antagonist (p < 0.01, n = 14;
Figure 5). Conversely, following activation of EGFP-VP neurons,
presympathetic responses were prevented by a 0 Ca2+/3 mM
EGTA aCSF (D 1.2 ± 0.2 mV, n = 10, p > 0.3), without altering
PVN-RVLM responses to direct uncaging of NMDA (D 5.5 ±
0.5 mV, p < 0.05, n = 4). These results support that Ca2+-depen-
dent dendritic release of VP (Ludwig et al., 2002) stimulates the
activity of neighboring presympathetic PVN neurons via activa-
tion of V1a receptors.
To rule out the possibility that PVN-RVLM neuronal responses
were due to diffusion of caged NMDA beyond the photoacti-
vated region in the EGFP-VP neurons, a subset of recorded
PVN-RVLM neurons was dialyzed with the NMDAR blocker
MK-801 (1 mM). Although intracellular MK801 significantly
blocked the effect of direct photolysis of caged NMDA onto
the recorded neurons (D 1.3 ± 0.9 mV; p > 0.2, n = 4), photolysis
onto EGFP-VP neurons still evoked a depolarizing response from
the same PVN-RVLM neurons (D 5.2 ± 1.4 mV; p < 0.05, n = 4)
(Figure S5). Additional controls included laser stimulation without
the presence of caged NMDA and bath application of caged
NMDA alone, both of which failed to evoke neuronal responses
(data not shown). Finally, NMDA uncaging onto EGFP-VP
neurons (n = 33) failed to evoke changes in [Ca2+]I in the vast
majority of Rhod-2-loaded astrocytes (87%). In the few
responsive astrocytes, increases in [Ca2+]I occurred with a long
delay (>40 s) (Figure S6).
To further prove the neurosecretory-presympathetic
neuronal crosstalk, we performed dual-patch recordings from
identified EGFP-VP and PVN-RVLM neurons. In 13 out of 15
pairs tested, we found that evoked burst firing in VP neurons
resulted in a significant membrane depolarization (p < 0.001;
n = 13) and increase in firing discharge (p < 0.02; n = 13) in
the neighboring presympathetic neurons (Figures 6B and 6F).
These effects were largely blocked following bath application
of the V1a antagonist (n = 7) or in pairs in which EGFP-VP neu-
rons were dialyzed with BAPTA (n = 5) (Figures 6C and 6F). No
responses were observed in the remaining two pairs. We found
that the latency for the evoked PVN-RVLM depolarization was
significantly longer when a prominent afterhyperpolarizing
potential (AHP) following the evoked bursts of action potentials
was observed in the paired EGFP-VP neuron (n = 9; Fig-
ure 6B1), compared to neurons in which AHPs were absent
(n = 6; Figure 6B2), or those in which a depolarizing afterpoten-
tial (DAP) was observed instead (n = 3; Figure 6D) (p < 0.001;
Figure 6E). Moreover, a significant correlation between the
EGFP-VP AHP duration and the PVN-RVLM latency was found
(Pearson r = 0.89; p < 0.0001). The mean latency in paired
recordings in which AHPs in EGFP-VP neurons were absent
was similar to that observed following photolysis of caged
NMDA (p > 0.3; see above), in which AHPs were not observed.
In contrast to the effect on latency, the magnitude of the PVN-
RVLM response was independent of the presence or duration
of an AHP in the stimulated EGFP-VP neurons (data not
shown).Finally, to determine whether astrocytes participate as inter-
mediaries in the neurosecretory-presympathetic crosstalk,
experiments were repeated following functional ablation ofNeuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc. 1041
Figure 6. Neurosecretory-Presympathetic
Crosstalk Unveiled during Dual-Patch
Recordings from EGFP-VP and PVN-RVLM
Neurons
(A) Sample pair of intracellularly labeled (Alexa
633; blue, arrows) PVN neurons during simulta-
neous dual-patch recordings. The identity of the
patched neurons as EGFP-VP (cyan, single arrow)
and retrogradely labeled PVN-RVLM (purple,
double arrow) is shown in (A2).
(B) Electrically evoked bursting activity in the
EGFP-VP neuron resulted in a delayed membrane
depolarization and increased firing discharge in
the neighboring PVN-RVLM neuron. Note the
pronounced AHP following action potential firing
in the EGFP-VP neuron (filled arrowhead). (B2)
Another sample of paired recordings showing a
similar response. Note, however, the lack of AHP
in the EGFP-VP neuron (empty arrowhead) and the
shorter latency of the evoked PVN-RVLM
response.
(C) Sample of a paired recording in which the
EGFP-VP neuron was dialyzed with BAPTA. Note
the lack of response in the PVN-RVLM neuron.
(D) Sample of a paired recording in the presence of
L-AAA (250 mM, 30 min), showing an increase in
PVN-RVLM firing activity following stimulation of
the EGFP-VP neuron. Note the presence of a DAP
in the EGFP-VP neuron (double filled arrowheads)
and the brief latency for the evoked PVN-RVLM
response.
(E) Comparison of the mean interneuronal-
coupling latency in EGFP-VP neurons displaying
or not an AHP following the evoked burst of action
potentials (n = 10 and 8, respectively).
(F) Summary data of mean changes in PVN-RVLM
membrane potential (left) and firing activity
(right) following direct stimulation of EGFP-VP
neurons in control ACSF (n = 13), V1a antagonist
(n = 7), intracellular BAPTA in the stimulated
EGFP-VP neuron (n = 5), and in the presence of
L-AAA (n = 5).
(G) Another representative example of dual-
patched and intracellularly labeled EGFP and
PVN-RVLM neurons. (G1) Single focal plane of a
confocal image showing EGFP-VP (green) and
PVN-RVLM (red) neurons. The recorded PVN-
RVLM neuron was intracellularly filled with
Alexa 633 (arrow; colocalization is indicated in
purple), and the recorded EGFP-VP neuron
was intracellularly filled with Alexa Fluor 555
(arrowhead; colocalization is indicated in
yellow). (G2) is the same image as in (A1), but a
confocal stack of ten images is shown to
better depict the dendritic processes of the
recorded neurons. The blue color has been
transformed to white for better clarity. Asterisk points to a dendritic end of the EGFP-VP (Alexa Fluor 555; filled) neuron. In (G3), the squared area in (G2) is shown
at a magnified scale.
Error bars represent SEM. **p < 0.001 versus AHP; +p < 0.05 and #p < 0.01 versus V1a antagonist and BAPTA, respectively. Scale bars represent 25 mm in (A1),
20 mm in (G1) and (G2), and 10 mm in (G3). Action potentials were cropped.
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Neurosecretory-Autonomic Interpopulation Crosstalkastrocytes with the selective gliotoxin L-aminoadipic acid
(L-AAA; 250 mM, 30–60 min) (McBean, 1994; Xu et al., 2008).
Under this condition, stimulation of EGFP-VP neurons still effi-
ciently evoked an excitatory response in PVN-RVLM neurons1042 Neuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc.(p < 0.001, n = 5; (Figures 6D and 6F). In a few cases (n = 4) in
which both neurons were intracellularly labeled with fluorescent
dyes, segments of dendrites from the paired neurons were found
in close proximity (12.5 ± 3.1 mm) (Figures 6G1–6G3).
Figure 7. An Activity-Dependent Diffusible Pool of Dendritically Released VP Tonically Modulates Presympathetic Neuronal Activity
(A) Sample trace showing a hyperpolarization and diminished firing discharge of a presympathetic neuron following bath application of the V1a receptor blocker
(1 mM). At the arrow, DC current injection was applied to bring the membrane potential back to control levels to show that the V1a antagonist efficiently blocked
the neuronal response to a VP puff (1 mM, arrowhead).
(B) Summary data of the effects of the V1a receptor antagonist on firing frequency and membrane potential of presympathetic neurons (n = 14).
(C) Sample trace showing a blunted effect of the V1a receptor antagonist in the presence of the k receptor agonist U-50488 (1 mM).
(D) Summary data of the effects of the V1a antagonist on presympathetic neuronal firing in control ACSF (K+ 2.5 mM), high K+ ACSF (8.0 mM), and in U-50488
(K+ 2.5 mM) (n = 6, 7 and 8, respectively).
(E) Sample traces and summary data showing the effects of the aminopeptidase blocker amastatin (10 mM, 10min) in control ACSF and in the presence of the V1a
receptor antagonist (n = 8 in each group).
Error bars represent SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S7.
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Stimulates Presympathetic Neuronal Activity
Our results demonstrate that evoked dendritic peptide release
from an individual VP neuron can diffuse locally to affect the
activity of a neighboring presympathetic neuron. We then tested
whether the basal average activity of the neurosecretory VP
population as awhole was sufficient to generate a tonic-diffusing
peptide pool, to continuously modulate presympathetic
neuronal activity. Blockade of V1a receptors per se resulted in
membrane hyperpolarization and inhibition of firing activity in
presympathetic neurons (p < 0.001 and p < 0.01, respectively,
n = 14; Figures 7A and 7B), unveiling the presence of a diffusible,
tonic pool of VP. Conversely, the firing activity of EGFP-VP neu-
rons was not affected (baseline, 2.2 ± 0.6 Hz; V1a antagonist,
2.2 ± 0.7 Hz; n = 5). To test whether the strength of the diffusible
pool was dependent on the degree of activity of the VP popula-
tion, we performed manipulations that either increased ordecreased VP neuronal activity. The VP tone was enhanced by
increasing extracellular K+ concentration (8.0 mM K+), as indi-
cated by a more pronounced effect of the V1a antagonist in
this condition, compared to normal K+ ACSF (p < 0.01; Fig-
ure 7D). Conversely, in the presence of the k opioid receptor
agonist U-50488 (1 mM), known to strongly inhibit VP neuronal
activity (p < 0.01; Figure S7A; see also Brown et al., 1998), the
V1a antagonist effect on presympathetic neuronal activity was
significantly blunted (p < 0.05 versus control; Figures 7C
and 7D). In the presence of the V1a antagonist, however,
U-50488 failed to affect the firing activity of presympathetic neu-
rons (p > 0.6, n = 4; Figure S7B), arguing against a direct effect of
U50488 on the latter. No correlation between basal PVN-RVLM
firing activity and the magnitude of the V1a antagonist
effect was found in any of these different conditions (Pearson
r = 0.02; p > 0.5). Dialysis of BAPTA into the recorded
PVN-RVLM neurons prevented the effects of the V1a antagonistNeuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc. 1043
Figure 8. Dendritic Release of VP within the
PVN Contributes to Sympathoexcitatory
Homeostatic Responses following aCentral
Hyperosmotic Challenge
(A) Representative traces showing changes in raw
(lower) and integrated (Int.; upper) RSNA following
administration of VP (16 pmol) onto the PVN.
(B) Summary data showing dose-dependent
increases in RSNA after microinjections of VP
(8, 16, and 32 pmol) onto the PVN (p < 0.02,
one-way ANOVA; n = 9).
(C) Representative traces showing changes in
RSNA following intracarotid infusions of an
isosmotic (NaCl 0.3 Osm/l) or hyperosmotic (NaCl
2.1 Osm/l) solution, following bilateral microinjec-
tions of ACSF or of the V1a receptor antagonist
(2 nmol/100 nl, 6–10 min before the osmotic
challenge) into the PVN. Note the increase in
RSNA evoked by the hyperosmotic challenge in
control ACSF (arrow), but not in the presence of
the V1a receptor antagonist.
(D) Summary data showing dose-dependent
increases in RSNA after intracarotid infusions of
NaCl (0.3, 0.9, and 2.1 Osm/l) in animals that
received an intra-PVN microinjection of either ACSF or the V1a receptor antagonist (*p < 0.0001 versus respective ACSF; n = 7).
(E) Summary data showing increased VP content in 30 min microdialysates sampled from the SON before and after an intracarotid infusion of NaCl 2.1 Osm/l
(arrow) (*p < 0.05 versus basal levels; n = 7).
Error bars represent SEM.
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Neurosecretory-Autonomic Interpopulation Crosstalk(baseline, 0.7 ± 0.1 Hz; V1a antagonist, 0.6 ± 0.1 Hz; p > 0.3,
n = 6).
A diffusible signal in the ECS could be influenced both by its
half-life and the ECS tortuosity. Blockade of tissue amino-
peptidase activity (amastatin 10 mM) increased the firing activity
of presympathetic neurons (p < 0.01, n = 8; Figure 7E). The
amastatin effect was not only blocked but also actually turned
into an inhibitory effect in the presence of the V1a receptor
blocker (p < 0.01 versus amastatin control, n = 7; Figure 7E).
These results indicate that aminopeptidase blockade increased
not only the availability and excitatory actions of endogenous VP
but also of an unknown inhibitory signal, which was only
unmasked when the VP excitatory effect was blocked. The
identity of this inhibitory peptide signal was not further investi-
gated in this study.
Reducing the coefficient of diffusion in the ECS with 5%
dextran (40 kDa) (Min et al., 1998; Piet et al., 2004) also blocked
the V1a antagonist effect on presympathetic firing discharge
(6.5% ± 8.8%; p > 0.6, n = 4). Taken together, these results
indicate that tonically released VP within the PVN serves as a
neurosecretory population signal, which acting in a diffusible
manner, increased the activity of the presympathetic PVN
neuronal population.
Dendritic Release of VP within the PVN Contributes
to the Recruitment of Sympathetic Neurons during
an Osmotic Challenge
We finally assessed whether dendritic release of VP serves as an
interpopulation signal by which the integrated sympathoex-
citatory output from the entire presympathetic neuronal popula-
tion was modulated. To this end, we performed in vivo studies to
directly monitor sympathoexcitatory outflow from the PVN. We
found that direct microinjection of VP (8–32 pmol) onto the1044 Neuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc.PVN elicited a dose-dependent sympathoexcitatory response,
reflected by an increase in renal sympathetic nerve activity
(RSNA; p < 0.02, n = 9; Figures 8A and 8B). These results indicate
that the VP excitatory effect observed on presympathetic
neurons in vitro translated into a systemic, population sympa-
thoexcitatory response.
It is well documented that a central osmotic challenge results
in a robust PVN homeostatic response that involves an orches-
trated activation of VP MNNs and presympathetic neurons,
leading to increased plasma VP levels along with a concomitant
increase in sympathetic outflow, respectively (Bourque, 2008;
Toney and Stocker, 2010). Thus, we used this paradigm to
assess the functional relevance of the neurosecretory-presym-
pathetic crosstalk in the context of a homeostatic challenge.
Intracarotid infusions of graded concentrations of NaCl (0.3,
0.9, and 2.1 Osm/l) induced a significant and dose-dependent
increase in RSNA (p < 0.0001, n = 7; Figures 8C and 8D). This
osmotically driven sympathoexcitatory response was signifi-
cantly attenuated (50%) by a previous bilateral microinjection
of the V1a antagonist within the PVN (2 nmol in 100 nl; p <
0.001 versus control; Figures 8C and 8D). As shown in Figure 8E,
the intracarotid osmotic stimulation evoked a significant
increase in VP release within the SON (p < 0.001, one-way
ANOVA repeated measures; n = 7). These results indicate
that osmotically driven dendritic VP release participates in
the recruitment of presympathetic neurons during a homeo-
static challenge requiring an orchestrated neurosecretory and
sympathetic response.
DISCUSSION
The two modalities by which the PVN commands the generation
of complex homeostatic responses are represented in distinct
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ting to the median eminence or the posterior pituitary, and
presympathetic neurons innervating the spinal cord and/or
brainstem nuclei, including the RVLM (Swanson and Saw-
chenko, 1980). Given its diverse, though well-characterized
anatomical and functional organization, the PVN stands as an
ideal brain region to study interpopulation signaling modalities
in the brain. Despite its highly integrative function, it is well docu-
mented that neurosecretory and presympathetic PVN neuronal
populations are anatomically compartmentalized, displaying a
minimal or complete lack of hardwired interconnections (Hatton
et al., 1985; Swanson and Kuypers, 1980; Swanson et al., 1980).
This has led to the notion that polymodal homeostatic control by
the PVN involves parallel processing of neuroendocrine and
autonomic information. In this study, we challenged this prevail-
ing idea by testing the hypothesis that dendritic release of
peptides serves as an interpopulation signal mediating crosstalk
between neurosecretory and presympathetic PVN neuronal
populations. Along with nigrostriatal dopaminergic neurons
(Cheramy et al., 1981), hypothalamic MNNs are one of the
best-characterized prototypes of dendritic neurotransmitter
release (Ludwig and Leng, 2006). Dendritic release of VP and
OT from MNNs acts as powerful feedback signals by which
MNNs autoregulate their own activity, to optimize systemic
hormone release in response to physiologically relevant chal-
lenges (Kombian et al., 1997; Ludwig and Leng, 1997). Results
from the present study demonstrate that in addition to its auto-
crine actions, VP acts as a diffusible signal to bridge information
across neurosecretory and presympathetic neuronal popula-
tions. This crosstalk involves Ca2+-dependent dendritic release
of VP, diffusion in the ECS, and activation of V1a VP receptors
coupled to a CAN channel in presympathetic neurons. Finally,
we demonstrate this crosstalk modality to be critical for an
optimal homeostatic sympathetic response to a central osmotic
challenge (Bourque, 2008; Toney and Stocker, 2010).
Dendritically Released VP Mediates a Neurosecretory-
to-Presympathetic Neuronal Crosstalk
We found that selective activation of a single neurosecretory VP
neuron (either by photolytic NMDA uncaging or direct current
injection in dual-patch recordings) evoked a V1a receptor-
mediated depolarization and firing discharge in neighboring
presympathetic (PVN-RVLM) neurons. Several lines of evidence
support that the underlying mechanism involved activation of a
CAN channel (Petersen, 2002), including (1) VP induced in
PVN-RVLM neurons an increase in [Ca2+]I that preceded the
enhanced membrane excitability; (2) intracellular Ca2+ depen-
dency of the VP effect; (3) voltage-dependent properties of IVP,
including an outwardly rectifying I/V curve; and (4) the IVP reversal
potential, characteristic of a mixed-cationic conductance.
Although our pharmacological (FFA), immunohistochemical,
and single-cell RT-PCR experiments (Figure S2) suggest the
involvement of TRPM4 channels, recently reported to be present
in MNNs (Teruyama et al., 2011), future studies are needed to
identify the precise molecular identity of the underlying CAN
channel.
Following bursts of action potentials, VP neurons express two
types of opposing postspike membrane potentials: AHPs andDAPs. These potentials temporally overlap, competing with
each other to either inhibit or increase postfiring membrane
excitability, respectively (Armstrong et al., 2010). We found that
when prominent AHPs were observed in the stimulated VP
neurons, the response latency of the presympathetic neurons
was prolonged. This suggests that AHPs act as a ‘‘braking’’
system that efficiently regulate activity-dependent dendritic VP
release and, consequently, the timing of the interneuronal cross-
talk in the PVN.
MNNs project almost exclusively to the posterior pituitary
(Swanson and Kuypers, 1980), with only a few reported cases
of scarce axon collaterals, arising from but terminating outside
the PVN (Hatton et al., 1985). Thus, the topographical segrega-
tion between the dendritic and axonal terminal fields of MNNs
minimized the possibility that photolytically evoked VP released
within the PVN originated from an axon terminal, rather than a
dendritic source. This is further supported by our results showing
that the evoked neurosecretory-presympathetic crosstalk
persisted in the presence of TTX, which prevents axonal but
not somatodendritic release of neuropeptides from MNNs.
Similar to dorsal raphe serotonin neurons (de Kock et al.,
2006), NMDA was shown to evoke dendritic release from
MNNs in the absence of action potentials (de Kock et al.,
2004), and dendritic VP release involves a Ca2+-dependent
exocytotic event (Ludwig et al., 2002). Accordingly, we found
that photolysis of caged NMDA in the somata of VP neurons
resulted in a rise in [Ca2+]i both in neuronal somata and dendrites.
This in turn was followed by an excitatory response in presympa-
thetic neurons, which was prevented by a synaptic block media.
Finally, intracellular Ca2+ chelation in VP neurons prevented
the neurosecretory-presympathetic coupling observed in dual-
patch recordings.
Although the combined anatomical, imaging, and electrophys-
iological data reported here strongly support a direct communi-
cation between neurosecretory and presympathetic neurons, we
cannot conclusively rule out the participation of other intermedi-
aries. For example, the evoked VP release from a single MNN
could act in a recurrent positive feedbackmanner to recruit addi-
tional VP neurons to release further amounts of VP (Kombian
et al., 1997; Ludwig and Leng, 1997). Moreover, dendritically
released VP could also act on nearby astrocytes to evoke release
of a potential gliotransmitter. However, our data showing that
stimulation of VP neurons failed to consistently activate nearby
astrocytes, and the fact that the neurosecretory-presympathetic
coupling persisted following ablation of astrocyte function,
would argue against this possibility.
Dendritically Released VP Acts as a Diffusible
Interpopulation Signal Contributing to Homeostatic
Neurohumoral Responses
Given its long half-life (20 min in the brain; Mens et al., 1983),
VP is ideally suited to act as a diffusible signal, potentially
affecting multiple neurons at relatively distant locations. We
found the firing activity of presympathetic PVN neurons to be
tonically stimulated by an endogenous VP ‘‘tone,’’ whose
strength was enhanced either by increasing the activity of VP
neurons or by prolonging VP lifetime in the ECS (aminopeptidase
block) (Chen and Pittman, 1999). Conversely, the strength of theNeuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc. 1045
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(k opioid agonist) (Brown et al., 1998) or when the coefficient of
diffusion of molecules in the ECS was lessened (5% dextran)
(Piet et al., 2004). Thus, our findings support the ability of den-
dritically released VP from the neurosecretory population to act
in a diffusible manner to modulate the activity of neighboring
presympathetic neurons.
A central hyperosmotic challenge triggers a coordinated
systemic release of VP, along with an increased RSNA (Bourque,
2008; Toney and Stocker, 2010). These responses are largely
mediated by activation of neurosecretory and presympathetic
SON/PVN neuronal populations, respectively (Antunes et al.,
2006; Chen and Toney, 2001; Leng et al., 2001; Oliet and
Bourque, 1993). In addition to systemic release, osmotic stimuli
also evoke local dendritic release of VP (Leng and Ludwig, 2008),
which serves as a ‘‘population feedback’’ signal by which VP
neurons autoregulate their own activity to optimize hormone
secretion from their axonal terminals (Gouze`nes et al., 1998). In
this study, we found that a hyperosmotic-induced increase in
RSNA was largely attenuated when V1a receptors within the
PVN were locally blocked.
Given that VP MNNs are intrinsically osmosensitive (Oliet and
Bourque, 1993), it is reasonable to speculate that osmotically
driven dendritic VP release effectively augmented the endoge-
nous neurosecretory VP tone, directly stimulating in turn the
neighboring presympathetic neuronal population. Alternatively,
dendritically released VP could also act by increasing presympa-
thetic neuronal responsiveness to forebrain glutamatergic
afferent inputs, known to contribute to osmotically driven
sympathetic responses by the PVN (Antunes et al., 2006; Shi
et al., 2007). This could occur either by strengthening osmosen-
sitive glutamatergic afferents (i.e., pre- or postsynaptically) or
simply by depolarizing the presympathetic resting membrane
potential closer to spike threshold. We found that VP excitatory
effects on presympathetic PVN neurons persisted in the pres-
ence of ionotropic glutamate receptor blockade, suggesting
that a direct VP excitatory signal per se is sufficiently strong to
evoke firing discharge and increase sympathetic outflow from
the presympathetic neuronal population.
The extent to which other PVN neuronal populations are also
targeted by dendritically released VP is at present unknown.
Clearly, recruitment specificity is a critical factor for the genera-
tion of a physiologically relevant homeostatic response, which is
likely achieved by the selective expression of V1a receptors in
the relevant neuronal populations.
Collectively, our findings provide, to the best of our knowl-
edge, the first demonstration that activity-dependent dendritic
release of peptides constitutes an efficient interpopulation
signaling modality in the brain. More specifically, they support
our hypothesis that a local crosstalk between hypothalamic
neurosecretory and presympathetic neuronal populations plays
an important role in the generation of central integrative
homeostatic responses (Pittman et al., 1982). Finally, given
that neurohumoral activation (a process involving elevated
neurosecretory and sympathetic outflows) is a hallmark in prev-
alent diseases such as hypertension and heart failure (Cohn
et al., 1984; Esler et al., 1995; Pliquett et al., 2004), our studies
provide insights into potentially pathophysiological mecha-1046 Neuron 78, 1036–1049, June 19, 2013 ª2013 Elsevier Inc.nisms contributing to morbidity and mortality in these prevalent
diseases.
EXPERIMENTAL PROCEDURES
Animals
Male Wistar rats (160–220 g) and male heterozygous transgenic VP-EGFP
Wistar rats (5–6 weeks old) were used (Ueta et al., 2005). All procedures
were carried out in agreement with the Georgia Regents University and the
University of Nebraska Medical Center Institutional Animal Care and Use
Committee guidelines, and were approved by the respective committees.
Retrograde Tracing
A total of 500 nl of rhodamine-labeledmicrospheres (Lumaflor) or cholera toxin
B (CTB) (1%; List Biological Laboratories) was microinjected into the RVLM
(starting from bregma: 12 mm caudal along the lamina, 2 mm medial lateral,
and 8 mm ventral). The location of the tracer was verified histologically by
Sonner et al. (2011). Animals were used 3–4 days after surgery.
Slice Preparation
Rats were anesthetized with pentobarbital (50 mg kg1), brains dissected out,
and coronal slices (200 mm) of the hypothalamus containing the PVN were cut
in an oxygenated ice-cold ACSF, as described by Sonner et al. (2011). For
synaptic blockade, a 0.2 mM CaCl2 and 400 mM CdCl2 ACSF was used. In
other cases, a 0 mM CaCl2/3 mM EGTA solution was used, as indicated.
Electrophysiology
Hypothalamic slices were transferred to a recording chamber and superfused
with ACSF (30C–32C) at a flow rate of 3.0 ml min1. Conventional whole-
cell patch-clamp recordings, using a K+-gluconate-based internal solution,
were obtained as previously described by Sonner et al. (2011). When noted,
neurons were intracellularly labeled with Alexa Fluor 555 (100 mM) or biocytin
(1%). Recordings were obtained from fluorescently labeled PVN-RVLM
neurons and from EGFP-VP neurons. For bath-applied drugs, mean firing
activity and membrane potential values were calculated from a 2 min period
before drug application and in a 2 min period around the peak effect. For
briefer applications (picospritzer) and uncaging, values were calculated from
a 1 min period before and 10–20 s period around the peak effect, using
Clampfit (Axon Instruments) or miniAnalysis (Synaptosoft) software.
Confocal Calcium Imaging
Neurons were loaded through the patch pipette with Fluo-5F pentapotassium
salt (100 mM; Molecular Probes), as previously described (Filosa et al., 2006;
Sonner et al., 2011). For astrocyte Ca2+ measurements, slices were incubated
in ACSF containing Rhod2-AM and pluronic acid (2.5 mg/ml). Imaging was con-
ducted using the Andor Technology Revolution system (iXON EMCCD camera
with the Yokogawa CSU 10, confocal scanning unit). Fluorescence images
were acquired at 488 nm and emitted light at >495 nm (Fluo5) or 561 nm
and emitted light >607 nm (Rhod2). Images were acquired at a rate of 4 Hz.
The fractional fluorescence (F/F0) was determined by dividing the fluorescence
intensity (F) within a region of interest (z4.8 3 4.8 mm) by a baseline fluores-
cence value (F0) determined from 30 images before photolysis of caged
NMDA. Data were analyzed using Andor IQ software (Andor Technology).
Photolysis of Caged Compounds
Slices were perfused with MNI-caged NMDA (50 mM). A UV laser excitation
(405 nm) was directed to a region of interest drawn on the image of identified
PVN-RVLM or EGFP-VP somata. Based on the pixel dwell time (200–800 ms)
and the ROI area scanned (40 mm2), the uncaging protocol lasted
180–720 ms. For these experiments, an ACSF containing 20 mM Mg2+ was
used to facilitate detection of evoked NMDA responses.
PVN Microinjections and In Vivo RSNA Measurements
Rats were anesthetized with urethane (0.75 g/kg i.p.) and a-chloralose (70 mg/
kg i.p.) and placed in a stereotaxic apparatus. The coordinates for PVN micro-
injections were 1.5 mm posterior to the bregma, 0.4 mm lateral to the midline,
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through a retroperitoneal flank incision. A branch of the renal nerve was
isolated and placed on a pair of thin bipolar platinum electrodes. The electrical
signal was amplified (10,000 times) with a Grass amplifier (P55) with a high-
and low-frequency cutoff of 1,000 and 100 Hz, respectively. The peak
response of RSNA to the administration of drugs into the PVN during the
experiment (averaged over a period of 20–30 s) was expressed as a percent
change from baseline (Biancardi et al., 2011).
Central Hyperosmotic Stimulation and VP Microdialysis
Injections of graded concentrations of NaCl (0.3, 0.9, and 2.1 Osm/l) were
delivered through an internal carotid artery (ICA) catheter in a volume of
300 ml over a period of 10–15 s. For microdialysis, microdialysis probes were
stereotaxically implanted with the U-shaped tip located within or adjacent to
the right SON, as previously described (Ludwig et al., 2002): 1.0 mm posterior
to bregma, 1.7 mm lateral to midline, 9.3 mm below the surface of the skull.
After an equilibration period of at least 1 hr, consecutive 30 min dialysis
samples were collected at a flow rate of 3 ml/min. After two 30 min baseline
periods, rats were stimulated osmotically as described above, and a further
two consecutive dialysate samples were collected, frozen, and stored at
20C until assay for VP. The VP content in themicrodialysates wasmeasured
by a highly sensitive and selective radioimmunoassay (Landgraf et al., 1995).
Immunohistochemistry
Rats were anesthetized with pentobarbital (50 mg kg1) and perfused
transcardially in 4% paraformaldehyde in 0.01 M PBS. Brains were then
removed, and coronal slices (30 mm) containing the PVN were cut and
incubated with one or a combination of the following primary antibodies: rabbit
(1:100; Millipore) or goat (1:50; Santa Cruz Biotechnology) anti-V1a receptor;
goat anti-CTB (1:2500; List Biological Laboratories); rabbit anti-TRPM4
(1:2,000; kindly donated by Dr. Teruyama, LHSU); rabbit anti-MAP2 (1:500;
Sigma-Aldrich); and mouse anti-DBH (1:20,000; Millipore). Incubation in
primary antibodies was followed by specific fluorescently labeled secondary
antibodies (1:250; Jackson ImmunoResearch Laboratories) for 4 hr. Slices
were then rinsed and visualized using confocal microscopy (Carl Zeiss
MicroImaging; 633 oil immersion, zoomed 32; single optical plane = 0.5 mm
thick) (Biancardi et al., 2010).
Single-Cell RT-PCR
Single-cell RT-PCR was carried out as previously described with minor modi-
fication (Sonner et al., 2011). The cytoplasm of the patched neuron, taking care
not to contain the nucleus, was pulled into a patch pipette containing 2 ml
DEPC-treated water and then mixed with 1 ml of RNase inhibitor (Applied
Biosystems). A nested approach was used to quantify V1a receptor mRNA.
The primers used included first-nested PCR (50-CGAGGTGAACAATGGCACT
AAAAC-30 and 50-TGTGATGGAAGGGTTTTCTGAATC-30), second-nested
PCR (50-TCATCTGCTACCACATCTGGCG-30 and 50-GTGTAACCAAAAGCC
CCTTATGAAAG-30), primers for TRPM4 (50-CCTGCAGGCCCAGGTAGA
GA-30 and 50-TTCAGCAGAGCGTCCATGAG-30), and GAPDH primers
(50-TTCAACGGCACAGTCAAGG-30 and 50-TGGTTCACACCCATCACAAA-30).
All primers were synthesized by Integrated DNA Technologies. Final PCR
products were electrophoresed on a 2% agarose gel in TAE buffer (40 mM
Tris-acetate, 1 mM EDTA [pH 8]) containing 0.5 mg/ml ethidium bromide,
observed UV light, and photographed.
Statistical Analysis
All values are expressed as mean ± SEM. In most cases, unpaired or paired
t tests were used, as indicated. One- or two-way ANOVA tests with Bonferroni
post hoc tests were used as needed. Pearson’s correlation test was used to
determine if correlations existed between two parameters. Differences were
considered significant at p < 0.05. All statistical analyses were conducted
using GraphPad Prism (GraphPad Software).
Drugs
All drugs with the exception of MNI-caged NMDA (Tocris) were purchased
from Sigma-Aldrich. For simplicity, the selective V1a antagonist b-mercapto-b,b-cyclopentamethylenepropionyl1, [O-me-Tyr2, Arg8]-VP (Sigma-Aldrich;
V2255) is referred to as ‘‘V1a antagonist’’ throughout the manuscript.
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